Tool Comparison
Finimize vs InvestorGain
- Paid from
- $16.67/mo
- Free plan
- Yes
- Platforms
- Web, Mobile
Best if
- You want stock ideas, news, and newsletters.
- Paid from
- —
- Free plan
- Yes
- Platforms
- Web, Mobile
Best if
- You want IPO, corporate actions & special situations, and new issues & calendars.
Pick Finimize if
Finimize
Free • From $200/yr · Web · Mobile
- You want stock ideas, news, and newsletters.
Pick InvestorGain if
InvestorGain
Free · Web · Mobile
- You want IPO, corporate actions & special situations, and new issues & calendars.
Skip both if: Neither one clicks with how you research; there are strong third options.
See alternativesOther tools you might like
Outbound links may include affiliate or sponsor codes.
Not set on either one? See the top 50 tools, ranked by user votes, or the deals page for big discounts on popular tools.
Our take
The bottom line
Finimize and InvestorGain cover a lot of the same ground (2 shared categories, education and blogs), so for the basics you won't go far wrong with either. Finimize includes stock ideas and news, and InvestorGain includes IPO and corporate actions & special situations.
What readers say
Finimize
No votes yet. Cast the first one.
InvestorGain
No votes yet. Cast the first one.
Key differences at a glance
- Global coverage
- InvestorGain
- Free trial
- Finimize7 days
- Asset coverage
- FinimizeAdds ETFs and cryptos
- Free plan
- Both
What Finimize does best
- Read the free daily newsletter for concise global market and investing news.
- Pro for investment ideas with analyst theses, entry points, risk factors, position sizing, ongoing coverage, and public performance tracking.
- Review model portfolios, live ideas, Quick Takes, analyst research, analysis, and advanced investing guides when comparing paid idea products.
- Browse US stock and ETF pages with intraday pricing and company data supplied by IEX.
- Listen to the Daily Brief through the mobile app.
What InvestorGain does best
- Track mainboard and SME IPO GMP, estimated listing price, Kostak rates, and GMP compared with actual listing performance.
- Monitor IPO subscription status with retail, NII, QIB, and total bid multiples.
- IPO calendars, allotment status pages, listing timelines, issue price bands, lot sizes, and post-listing outcomes from one public web/mobile portal.
- Review anchor investor allocation reports by year for mainboard and SME IPOs.
- Compare issue price, listing price, listing gain, and later performance with the earlier GMP estimate.
Side by side
Pricing comparison
See for yourself
Side by side
Price, platforms, data, and market coverage.ShowHide
Side by side
| Attribute | ||
|---|---|---|
| Pricing & plans | ||
Starting price | Free • From $200/yr | Free |
Free tier | Yes | Yes |
Free trial | 7 days | — |
Plan limits | Pro (Annual): refund period days: 14 | — |
| Platforms & access | ||
Web app | Yes | Yes |
Mobile app | Yes | Yes |
API access | No | No |
Broker sync | No | No |
| Audience & fit | ||
Experience level | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Best for | — | — |
Categories covered | 5 | 6 |
Regions | North America | APAC |
| Data & capabilities | ||
Data quality | Latency: Real-time | 4 signals: Latency: Real-time and End of Day, Granularity: Minute and EOD +2 more |
| Try it | Visit Finimize | Visit InvestorGain |
Standout features
The best features of Finimize and InvestorGain.ShowHide
Standout features
What Finimize does best
- Read the free daily newsletter for concise global market and investing news.
- Pro for investment ideas with analyst theses, entry points, risk factors, position sizing, ongoing coverage, and public performance tracking.
- Review model portfolios, live ideas, Quick Takes, analyst research, analysis, and advanced investing guides when comparing paid idea products.
- Browse US stock and ETF pages with intraday pricing and company data supplied by IEX.
- Listen to the Daily Brief through the mobile app.
What InvestorGain does best
- Track mainboard and SME IPO GMP, estimated listing price, Kostak rates, and GMP compared with actual listing performance.
- Monitor IPO subscription status with retail, NII, QIB, and total bid multiples.
- IPO calendars, allotment status pages, listing timelines, issue price bands, lot sizes, and post-listing outcomes from one public web/mobile portal.
- Review anchor investor allocation reports by year for mainboard and SME IPOs.
- Compare issue price, listing price, listing gain, and later performance with the earlier GMP estimate.
All details
Every attribute we track for Finimize and InvestorGain.ShowHide
All details
| Attribute | ||
|---|---|---|
| Coverage & fit | ||
Asset types | StocksETFsCryptosCommoditiesCurrenciesBonds | StocksBonds |
Experience | BeginnerIntermediateAdvanced | BeginnerIntermediateAdvanced |
Regions | North America | APAC |
Coverage details | Countries: USIdentifiers: Ticker | Countries: INExchanges: XBOM and XNSEIdentifiers: Ticker |
| Data | ||
Data freshness | Real-time | Real-timeEnd of Day |
Data granularity | Not specified | MinuteEOD |
| Plans & trust | ||
Vendor & support | Finimize LtdCountry: United KingdomFounded 2016Support: Email | Primish Infotech Private LimitedCountry: IndiaFounded 2015Support: Email |
Curation ratings | Methodology 3/5Reliability 4/5UX 4/5 | Methodology 3/5Reliability 3/5UX 4/5 |
Green tags are exclusive to that tool in this comparison.
Pricing
Plans, billing, free trials, and monthly prices.ShowHide
Pricing
| Tier | ||
|---|---|---|
| Free plan | Free | Free |
| Entry paid plan | $200/yr≈ $16.67/mo“Pro (Annual)”refund period days: 14 | — |
| Free trial | 7 days | — |
Alternatives
Free alternatives
Questions we keep getting
What's the difference between Finimize and InvestorGain?
Finimize leans toward stock ideas, news, and education, while InvestorGain puts more weight on IPO, corporate actions & special situations, and new issues & calendars. They overlap in 2 categories, so for most people it comes down to workflow preference and price.
How much do Finimize and InvestorGain cost?
Good news: both Finimize and InvestorGain have free plans, so you can run them side by side and only pay if you hit a wall.
Should I choose Finimize or InvestorGain?
It depends on what you're after. Pick Finimize if stock ideas and news matter to you; go with InvestorGain if you'd rather have IPO and corporate actions & special situations. And if you only need the basics both share, let price decide.
What asset classes do Finimize and InvestorGain cover?
Both cover stocks and bonds. Finimize also handles ETFs, cryptos, and commodities.
Do Finimize and InvestorGain offer real-time data?
Yes, both serve real-time market data, so either works when timing matters.
Which covers international markets: Finimize or InvestorGain?
InvestorGain has documented international coverage (APAC), so it's the safer bet if you hold non-US stocks. Finimize is more region-specific, mainly North America.
Keep researching
Other tools you might like
Keep Exploring
Feedback
Spot stale pricing, missing features, or a comparison that feels off? Send feedback on the verdict, table, alternatives, or recommendation.
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.